CompletedPhase 3NCT00257530

Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Drugs for Neglected Diseases
Principal Investigator
Catherine Royce, Dr
Drugs for Neglected Diseases initiative
Intervention
Imiquimod(drug)
Enrollment
80 target
Eligibility
5-65 years · All sexes
Timeline
20052006

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00257530 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis

← Back to all trials